Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trials
Authors:
- Gary B. WeissGWGary B. Weiss
- Harvey BunceHBHarvey Bunce
- Hokanson James A.HAHokanson James A.
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 4 (1-2) , 43-52
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical dataCancer, 1981
- Low tissue enzyme activity seen in breast cancers of patients who fail adjuvant chemotherapyCancer, 1981
- Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lungCancer, 1981
- Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapyCancer, 1980
- Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patientsCancer, 1980
- A phase II study of peptichemio in advanced breast cancerCancer, 1980
- Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum.A prospective randomized studyCancer, 1979
- Clinical trials in cancer chemotherapyCancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976